NCT03662139

Brief Summary

The purpose of this study is to assess validity and reliability of Dynamic Gait Index (DGI) in patients with unilateral spastic cerebral palsy

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2018

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 5, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 7, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
11 months until next milestone

Results Posted

Study results publicly available

November 5, 2019

Completed
Last Updated

January 29, 2020

Status Verified

November 1, 2019

Enrollment Period

3 months

First QC Date

September 5, 2018

Results QC Date

June 11, 2019

Last Update Submit

January 24, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Dynamic Gait Index (DGI)

    Dynamic Gait Index is a tool consisting eight items; gait on a flat surface, changing speed, gait with horizontal and vertical head turns, pivot turn, stepping over obstacle, Minimum score is 0, maximum score is 24, higher scores indicate better outcome. Scores lower than 19 indicate risk of falling and above 22 define safe ambulance.

    Day 1 (Baseline) in both groups (Cerebral Palsy group same day by two different evaluators), Day 7-10 in the Cerebral Palsy group only

Secondary Outcomes (3)

  • Pediatric Balance Scale (PBS)

    Only Day 1 in both Cerebral Palsy and Healthy control groups (Cerebral Palsy group same day by two different evaluators)

  • Timed Up and Go Test (TUG)

    Only Day 1 in both Cerebral Palsy and Healthy control groups (Cerebral Palsy group same day by two different evaluators)

  • Four Square Step Test (FSST)

    Only Day 1 in both Cerebral Palsy and Healthy control groups (Cerebral Palsy group same day by two different evaluators)

Study Arms (2)

Cerebral Palsy Group

16 patients will be included. Dynamic Gait Index and other assessments will be performed twice with a 7 - 10 day interval by two evaluators

Other: Dynamic Gait Index

Healthy Control Group

16 healthy children will be included. Dynamic Gait Index and other assessments will be performed twice with a 7 - 10 day interval by two evaluators

Other: Dynamic Gait Index

Interventions

Dynamic Gait Index is a clinical tool for assessing functional balance and gait variability in people with neurologic conditions

Cerebral Palsy GroupHealthy Control Group

Eligibility Criteria

Age6 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

16 spastic unilateral cerebral palsy patients, between 6 - 14 years of age, and 16 healthy volunteer peers

You may qualify if:

  • Confirmed diagnosis of spastic unilateral cerebral palsy
  • Age between 4 - 16
  • Able to stand and walk without any orthosis or special equipment
  • Volunteer to study

You may not qualify if:

  • Being unable to walk
  • Having cognitive disorder
  • History of orthopedic surgery or any intervention for spasticity within the previous 12 months
  • Uncontrolled epilepsy
  • Visual conditions that prevent full participation to assessments
  • Lower extremity contracture that may affect assessments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University School of Medicine, Pendik Research and Education Hospital, Department of Physical Medicine and Rehabilitation

Istanbul, 34899, Turkey (Türkiye)

Location

Related Publications (6)

  • Franjoine MR, Gunther JS, Taylor MJ. Pediatric balance scale: a modified version of the berg balance scale for the school-age child with mild to moderate motor impairment. Pediatr Phys Ther. 2003 Summer;15(2):114-28. doi: 10.1097/01.PEP.0000068117.48023.18.

    PMID: 17057441BACKGROUND
  • Shumway-Cook A, Taylor CS, Matsuda PN, Studer MT, Whetten BK. Expanding the scoring system for the Dynamic Gait Index. Phys Ther. 2013 Nov;93(11):1493-506. doi: 10.2522/ptj.20130035. Epub 2013 Jun 27.

    PMID: 23813090BACKGROUND
  • Bandong AN, Madriaga GO, Gorgon EJ. Reliability and validity of the Four Square Step Test in children with cerebral palsy and Down syndrome. Res Dev Disabil. 2015 Dec;47:39-47. doi: 10.1016/j.ridd.2015.08.012. Epub 2015 Aug 27.

    PMID: 26318393BACKGROUND
  • Carey H, Martin K, Combs-Miller S, Heathcock JC. Reliability and Responsiveness of the Timed Up and Go Test in Children With Cerebral Palsy. Pediatr Phys Ther. 2016 winter;28(4):401-8. doi: 10.1097/PEP.0000000000000301.

    PMID: 27661230BACKGROUND
  • Rosenbaum P, Paneth N, Leviton A, Goldstein M, Bax M, Damiano D, Dan B, Jacobsson B. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007 Feb;109:8-14.

    PMID: 17370477BACKGROUND
  • Evkaya A, Karadag-Saygi E, Karali Bingul D, Giray E. Validity and reliability of the Dynamic Gait Index in children with hemiplegic cerebral palsy. Gait Posture. 2020 Jan;75:28-33. doi: 10.1016/j.gaitpost.2019.09.024. Epub 2019 Sep 23.

MeSH Terms

Conditions

Cerebral PalsyGait Disorders, Neurologic

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Naime Evrim Karadag-Saygi, Prof. Dr.
Organization
Department of PM&R, Marmara University School of Medicine

Study Officials

  • Naime Evrim Karadag Saygi, Prof

    Department of PM&R, Marmara University School of Medicine

    STUDY CHAIR
  • Ayca Evkaya, PT

    Department of PM&R, Marmara University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2018

First Posted

September 7, 2018

Study Start

April 1, 2018

Primary Completion

June 30, 2018

Study Completion

December 1, 2018

Last Updated

January 29, 2020

Results First Posted

November 5, 2019

Record last verified: 2019-11

Locations